21187731

Source:http://linkedlifedata.com/resource/pubmed/id/21187731

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0079280, umls-concept:C0087111, umls-concept:C0238767, umls-concept:C1554888
pubmed:issue	1
pubmed:dateCreated	2010-12-28
pubmed:abstractText	The purpose of this study was to review adverse events and patient preference after bilateral intravitreal injection of antibodies to vascular endothelial growth factor.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309919
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized, http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A, http://linkedlifedata.com/resource/pubmed/chemical/bevacizumab, http://linkedlifedata.com/resource/pubmed/chemical/ranibizumab
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	1539-2864
pubmed:author	pubmed-author:AbràmoffMichael DMD, pubmed-author:BoldtH CulverHC, pubmed-author:ElkinsKori AKA, pubmed-author:FolkJames CJC, pubmed-author:GehrsKaren MKM, pubmed-author:LiuDaweiD, pubmed-author:MahajanVinit BVB, pubmed-author:RussellStephen RSR, pubmed-author:StoneEdwin MEM, pubmed-author:WeingeistThomas ATA
pubmed:issnType	Electronic
pubmed:volume	31
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	31-5
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:21187731-Aged, pubmed-meshheading:21187731-Aged, 80 and over, pubmed-meshheading:21187731-Antibodies, Monoclonal, pubmed-meshheading:21187731-Antibodies, Monoclonal, Humanized, pubmed-meshheading:21187731-Case-Control Studies, pubmed-meshheading:21187731-Drug Administration Schedule, pubmed-meshheading:21187731-Drug Combinations, pubmed-meshheading:21187731-Female, pubmed-meshheading:21187731-Follow-Up Studies, pubmed-meshheading:21187731-Humans, pubmed-meshheading:21187731-Incidence, pubmed-meshheading:21187731-Injections, Intraocular, pubmed-meshheading:21187731-Macular Degeneration, pubmed-meshheading:21187731-Male, pubmed-meshheading:21187731-Middle Aged, pubmed-meshheading:21187731-Myocardial Infarction, pubmed-meshheading:21187731-Patient Preference, pubmed-meshheading:21187731-Retrospective Studies, pubmed-meshheading:21187731-Vascular Endothelial Growth Factor A, pubmed-meshheading:21187731-Vitreous Body
pubmed:year	2011
pubmed:articleTitle	Bilateral intravitreal injection of antivascular endothelial growth factor therapy.
pubmed:affiliation	Department of Ophthalmology and Visual Sciences, The University of Iowa Hospitals & Clinics, Iowa City, IA, USA. mahajanlab@gmail.com
pubmed:publicationType	Journal Article, Comparative Study, Research Support, Non-U.S. Gov't